tiprankstipranks
Advertisement
Advertisement

HK:2652 Stock Latest News

CF PharmTech Wins Expanded Trial Approvals for Inhaled Lung Disease Candidate ICF001
Company AnnouncementsCF PharmTech Wins Expanded Trial Approvals for Inhaled Lung Disease Candidate ICF001
4d ago
2652
CF PharmTech Board to Review Interim Results and Consider Dividend
PremiumCompany Announcements
CF PharmTech Board to Review Interim Results and Consider Dividend
9d ago
2652
CF PharmTech completes HK$13.82 H-share placing to broaden investor base
PremiumCompany Announcements
CF PharmTech completes HK$13.82 H-share placing to broaden investor base
22d ago
2652
CF PharmTech Launches Discounted HK$300 Million H-Share Placing
PremiumCompany Announcements
CF PharmTech Launches Discounted HK$300 Million H-Share Placing
29d ago
2652
CF PharmTech AGM Approves 2025 Results and Elects New Board
PremiumCompany Announcements
CF PharmTech AGM Approves 2025 Results and Elects New Board
2M ago
2652
CF PharmTech details board and committee structure
PremiumCompany AnnouncementsCF PharmTech details board and committee structure
2M ago
2652
CF PharmTech cuts H-share board lot size to boost liquidity
Premium
Company Announcements
CF PharmTech cuts H-share board lot size to boost liquidity
2M ago
2652
CF PharmTech Wins PIC/S GMP Clearance for Suzhou Inhalation Plant
Premium
Company Announcements
CF PharmTech Wins PIC/S GMP Clearance for Suzhou Inhalation Plant
3M ago
2652
CF PharmTech Sets June 2026 AGM to Renew Board, Expand Share Incentive Scheme and Seek New Share Issue Mandate
PremiumCompany Announcements
CF PharmTech Sets June 2026 AGM to Renew Board, Expand Share Incentive Scheme and Seek New Share Issue Mandate
3M ago
2652
CF PharmTech Wins NMPA IND Nod for First-in-Class Inhaled Lung Disease Drug
PremiumCompany Announcements
CF PharmTech Wins NMPA IND Nod for First-in-Class Inhaled Lung Disease Drug
3M ago
2652
CF PharmTech Reshapes Board and Supervisory Leadership Ahead of AGM
PremiumCompany Announcements
CF PharmTech Reshapes Board and Supervisory Leadership Ahead of AGM
3M ago
2652
CF PharmTech Outlines Board and Committee Structure to Strengthen Governance
PremiumCompany Announcements
CF PharmTech Outlines Board and Committee Structure to Strengthen Governance
3M ago
2652
CF PharmTech Files for CF017 Marketing Approval in Key Southeast Asian Market
PremiumCompany AnnouncementsCF PharmTech Files for CF017 Marketing Approval in Key Southeast Asian Market
3M ago
2652
CF PharmTech’s COPD Inhalation Therapy Accepted for NMPA Review
Premium
Company Announcements
CF PharmTech’s COPD Inhalation Therapy Accepted for NMPA Review
3M ago
2652
CF PharmTech Endures Transitional Year as Revenue Falls Amid Strategy Shift
Premium
Company Announcements
CF PharmTech Endures Transitional Year as Revenue Falls Amid Strategy Shift
5M ago
2652
CF PharmTech Taps JD Health as Exclusive Online Partner for New Respiratory Drugs
PremiumCompany Announcements
CF PharmTech Taps JD Health as Exclusive Online Partner for New Respiratory Drugs
5M ago
2652
CF PharmTech Issues Profit Warning as VBP Pressure Hits 2025 Earnings
PremiumCompany Announcements
CF PharmTech Issues Profit Warning as VBP Pressure Hits 2025 Earnings
5M ago
2652
CF PharmTech Sets Board Meeting to Approve 2025 Annual Results and Consider Final Dividend
PremiumCompany Announcements
CF PharmTech Sets Board Meeting to Approve 2025 Annual Results and Consider Final Dividend
5M ago
2652
CF PharmTech Wins NMPA IND Acceptance for Novel Inhaled Pulmonary Hypertension Drug
PremiumCompany Announcements
CF PharmTech Wins NMPA IND Acceptance for Novel Inhaled Pulmonary Hypertension Drug
6M ago
2652
CF PharmTech Wins NMPA Nod for Clinical Trials of New Combination Nasal Spray
PremiumCompany AnnouncementsCF PharmTech Wins NMPA Nod for Clinical Trials of New Combination Nasal Spray
6M ago
2652
CF PharmTech H Shares Added to Shanghai and Shenzhen-Hong Kong Stock Connect
Premium
Company Announcements
CF PharmTech H Shares Added to Shanghai and Shenzhen-Hong Kong Stock Connect
6M ago
2652
CF PharmTech Wins NMPA IND Acceptance for Inhaled Lung Fibrosis Drug ICF004
Premium
Company Announcements
CF PharmTech Wins NMPA IND Acceptance for Inhaled Lung Fibrosis Drug ICF004
6M ago
2652

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >